Challenges in Combining Antiangiogenic Therapy With Transarterial Chemoembolization for Hepatocellular Carcinoma

BACKGROUND: The combination of systemic antiangiogenic therapy and transarterial chemoembolization (TACE) for the treatment of unresectable hepatocellular carcinoma (HCC) is the subject of several ongoing clinical trials. We present a series of patients treated with sorafenib and TACE at our institu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Haydar, Ali A., Mukherji, Deborah, Faraj, Walid, Khalifeh, Mohammad, Taslakian, Bedros, Yehia, Zeinab Abou, Temraz, Sally, Brown, Karen T., Abou-Alfa, Ghassan K., Shamseddine, Ali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Society of Gastrointestinal Oncology 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171975/
https://ncbi.nlm.nih.gov/pubmed/25276263
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak